United States Cryptococcosis Market Size & Outlook, 2026-2034


United States Cryptococcosis Market Insights

  • Reed Intelligence analysis indicates that the United States Cryptococcosis Market size, valued at USD 209.35 Million in 2025, is expected to expand to USD 373.23 Million by 2034.
  • The United States market is forecasted to expand at a CAGR of 6.67% spanning 2026–2034.
  • Azoles held the leading position among By Drug Class segments in 2025, based on market size.
  • Combination Therapy is projected to post the fastest growth rate, sustaining its position as the most attractive By Drug Class segment during the forecast horizon.

Other Key Findings


  • United States accounted for 30.79% of the global Cryptococcosis Market size in 2025.
  • By 2034, United States is expected to remain the top global market in terms of size.
  • Within North America, United States is forecasted to dominate the regional Cryptococcosis Market size by 2034.
  • United States will be the fastest-growing market in North America, projected to achieve USD 374.33 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 209.35 Million
Market Size In 2034 USD 373.23 Million
Largest segment Azoles
Units Revenue in USD Million
CAGR 6.67% (2026-2034)
Segmnetation Covered
By Drug Class
  1. Azoles
  2. Polyenes
  3. Flucytosine
  4. Combination Therapy
By Indication
  1. Cryptococcal Meningitis
  2. Pulmonary Cryptococcosis
  3. Disseminated Cryptococcosis
By Route of Administration
  1. Oral
  2. Intravenous
By End-Use
  1. Hospitals
  2. Specialty Clinics
  3. Research Institutes
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends